The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn’s disease – a phase 1 trial with three doses
Background Mesenchymal stromal cells ability to reset immune functionalities may be useful in Crohn's disease. Aim To perform a first-in-human phase 1 safety clinical trial of metabolically fit autologous bone…